7 citations
,
June 1978 in “Archives of Dermatology”
This article describes a case in which a gymnast's hair loss pattern improved after she stopped using the balancebeam, suggesting the hair loss may have been due to traction from her gymnastics routine.
This case-control study found that men with earlier onset androgenetic alopecia, particularly frontal balding, may have an increased risk of prostate cancer in a multiethnic veterans cohort.
The authors describe drug repurposing as a promising strategy for finding new uses for existing drugs, noting it is efficient, cost-effective, and poses lower risks than traditional drug discovery processes, potentially aiding in the treatment of rare and difficult-to-treat diseases.
15 citations
,
February 2014 in “BMC Research Notes”
This study found that male androgenic alopecia patients using the X5 hair laser device showed a statistically significant increase in hair growth over a 26-week period.
Patchy hair loss or alopecia areata: is there any evidence for Baicapil?There is no published trial of Baicapil in alopecia areata. The anti-inflammatory and hair-density claims come from the ingredient's manufacturer and from laboratory work on its plant extracts; none of it involved people with autoimmune patchy hair loss.
Is bimatoprost effective for people with alopecia areata?Bimatoprost is approved only for eyelashes; for alopecia areata the evidence is a few small studies with mixed results. Near the eyes it can darken the iris, a change its label says is likely to be permanent.
What do the latest studies say about bimatoprost for scalp hair growth?Bimatoprost is approved only for eyelashes; a single 30-person pilot reported better results than a topical steroid on patches of alopecia areata, but the two registered Allergan trials in male pattern hair loss were never published and never taken further, so scalp use stays off-label and experimental.